Cannabix Technologies Inc
CNSX:BLO
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.17
0.81
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Cannabix Technologies Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | CA |
Market Cap | 42.8m CAD |
Net Margin | N/A |
Country | JP |
Market Cap | 15.9T JPY |
Net Margin |
38%
|
Country | CN |
Market Cap | 280.1B CNY |
Net Margin |
14%
|
Country | US |
Market Cap | 29.4B USD |
Net Margin |
12%
|
Country | US |
Market Cap | 22.6B USD |
Net Margin |
17%
|
Country | SE |
Market Cap | 246.6B SEK |
Net Margin |
19%
|
Country | US |
Market Cap | 20.5B USD |
Net Margin |
8%
|
Country | US |
Market Cap | 17.7B USD |
Net Margin |
41%
|
Country | IL |
Market Cap | 14.6B USD |
Net Margin |
-164%
|
Country | UK |
Market Cap | 10.2B GBP |
Net Margin |
13%
|
Country | JP |
Market Cap | 1.3T JPY |
Net Margin |
10%
|
Cannabix Technologies Inc
Glance View
Cannabix Technologies, Inc. engages in the development and manufacturing of marijuana breathalyzer for law enforcement. The company is headquartered in Burnaby, British Columbia. The company went IPO on 2013-12-16. The firm is engaged in developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. The company is using a field asymmetric ion mobility spectrometry (FAIMS) technology to detect 9-tetrahydrocannabinol (THC), a non-volatile compound, in breath. Its FAIMS device is designed to operate both independently and coupled in tandem directly to a mass spectrometer (MS), used in forensic labs. Its THC Breath Analyzer (THCBA) is a point of care breath testing tool for the rapid detection of recent cannabis use. THCBA collects a single breath from the user and the sensor response is represented by a characteristic pattern or smell-print to the specific target gas. The THCBA has been built to provide easy to understand screen prompts for the positive and negative detection of THC in breath in a portable manner.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Cannabix Technologies Inc's most recent financial statements, the company has Net Margin of 0%.